Evidence map›Paper›PMID 42472586›Full record

ReviewClinical medicine (London, England)2026

HIV update for the non-HIV specialist and general physician.

Miriam Ringshall, Jaime H Vera

Abstract readReview
In one paragraph

Review in Clinical medicine (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Miriam RingshallUniversity Hospitals Sussex NHS Foundation Trust, Eastern Road, Brighton BN2 5BE, UK. Electronic address: m.ringshall@nhs.net.
Jaime H VeraUniversity Hospitals Sussex NHS Foundation Trust, Eastern Road, Brighton BN2 5BE, UK; Department of Global Health and Infection, Brighton and Sussex Medical School, University of Sussex, Brighton BN1 9PX, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

HIV has become a manageable chronic condition, one of the major successes of modern medicine. People living with HIV can now expect near-normal life expectancy with effective treatment, yet important challenges remain. Comorbidities, prevention of new infections, and the persistence of stigma continue to affect outcomes. Addressing these issues requires coordinated care, with general practice, hospital services and specialist HIV teams working closely together. This article aims to support healthcare professionals by summarising current best practice in treatment, outlining advances in prevention and early diagnosis, and exploring how stigma can be reduced both within healthcare and in the wider community. These efforts are essential if the UK is to meet its goal of ending new HIV transmissions by 2030.

Indexed as

Antiretroviral therapyHIV

Identifiers

PMID42472586
PMCPMC13487612

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.